To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Bidirectional association between inflammatory bowel disease and type 1 diabetes: a nationwide matched cohort and case-control study
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden; Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Örebro University, School of Medical Sciences. Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.ORCID iD: 0000-0003-0122-7234
Show others and affiliations
2024 (English)In: The Lancet Regional Health: Europe, E-ISSN 2666-7762, Vol. 46, article id 101056Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Co-occurrence of inflammatory bowel disease (IBD) and type 1 diabetes (T1D) has been linked to poor clinical outcomes, but evidence on their bidirectional associations remain scarce. This study aims to investigate their bidirectional associations.

METHODS: A nationwide matched cohort and case-control study with IBD patients identified between 1987 and 2017. The cohort study included 20,314 IBD patients (≤28 years; Crohn's disease [CD, n = 7277], ulcerative colitis [UC, n = 10,112], and IBD-unclassified [IBD-U, n = 2925]) and 99,200 individually matched reference individuals, with a follow-up until December 2021. The case-control study enrolled 87,001 IBD patients (no age restriction) and 431,054 matched controls. We estimated adjusted hazard ratio (aHR) of incident T1D in the cohort study with flexible parametric survival model and adjusted odds ratio (aOR) of having a prior T1D in the case-control study with conditional logistic regression model, with 95% confidence intervals (CI).

FINDINGS: During a median follow-up of 14 years, 116 IBD patients and 353 reference individuals developed T1D. Patients with IBD had a higher hazard of developing T1D (aHR = 1.58 [95% CI = 1.27-1.95]). The hazard was increased in UC (aHR = 2.02 [1.51-2.70]) but not in CD or IBD-U. In the case-control study, a total of 1018 (1.2%) IBD patients and 3496 (0.8%) controls had been previously diagnosed with T1D. IBD patients had higher odds of having prior T1D (aOR = 1.36 [1.26-1.46]). Such positive association was observed in all IBD subtypes. The sibling comparison analyses showed similar associations between IBD and T1D (aHR = 1.44 [0.97-2.15] and aOR = 1.32 [1.18-1.49]).

INTERPRETATION: Patients with IBD had a moderately increased hazard of developing T1D and higher odds of having prior T1D. Their bidirectional associations may be partially independent of shared familial factors.

Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 46, article id 101056
Keywords [en]
Case–control, Cohort, Inflammatory bowel disease, Nationwide, Type 1 diabetes
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:oru:diva-116089DOI: 10.1016/j.lanepe.2024.101056ISI: 001316926800001PubMedID: 39286331Scopus ID: 2-s2.0-85202583169OAI: oai:DiVA.org:oru-116089DiVA, id: diva2:1898840
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2016-00424
Note

This study was supported by the European Crohn's and Colitis Organisation (to JS; grant number: not applicable), the Stiftelsen Professor Nanna Svartz Fond (to JS; grant number: not applicable), SSMF (to JS; grant number: PG-23-0315-H-02), the Ruth and Richard Julin Foundation (to JS; grant number: not applicable) and FORTE (to JFL; grant number: 2016-00424).

Available from: 2024-09-18 Created: 2024-09-18 Last updated: 2025-02-11Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Halfvarson, JonasLudvigsson, Jonas F.

Search in DiVA

By author/editor
Halfvarson, JonasLudvigsson, Jonas F.
By organisation
School of Medical SciencesÖrebro University Hospital
In the same journal
The Lancet Regional Health: Europe
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 147 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf